It helps to penetrate deep inside the skin cells and causes the transformation within a few days
References Chang, C.H., Tsai, W.C., Lin, M.S., Hsu, Y.H., & Pang, J.H
Published protocols provide starting points for: Topical application frequencies (often once or twice daily) Subcutaneous injection volumes and concentrations near wound sites Systemic dosing regimens in organ injury models Treatment durations (typically 7-28 days for wound studies) Key Outcome Measures Established outcome measures in rodent GHK-Cu research include: Experimental Design Recommendations Future studies should incorporate: Careful monitoring of copper status throughout treatment periods Appropriate control groups including vehicle control, copper-free peptide control, and free copper controls where relevant Detailed methodology reporting for reproducibility Assessment of potential off-target effects through standard toxicology panels Consideration of sex differences, given that some regenerative processes show sex-dependent responses Researchers interested in overall skin health, skin rejuvenation, or anti aging mechanisms may also consider combining GHK-Cu with other peptides or active ingredients (such as vitamin c or chemical peels in post procedure recovery models) to examine synergistic effects
Rather than being a pharmaceutical development, this tripeptide occurs naturally in human blood plasma, with concentrations around 200 ng/mL at age 20 that decline to approximately 80 ng/mL by age 60
